Hypoxia inducible factor 1α (HIF-1α) is a major cancer driver (Ortmann et al., 2014) and a potential therapeutic target (Brown and Wilson, 2004; Vaupel and Mayer, 2007; Wilson and Hay, 2011). This evidence concerns the gene HIF1A and cancer.